EU fines pharma firms over generics delay (Update)
(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives to a ...
Jun 19, 2013
0
0